ALEXANDRIA REAL ESTATE EQUITIES, INC.
Close on Oct 19, 2026
- Market cap
- $6.94B
- P/E (TTM)
- –
- Dividend yield
- 11.52%
About Alexandria Real Estate Equities
Real Estate Investment Trusts, SIC 6798
The provided text contains XBRL accounting data and taxonomy labels rather than descriptive business narrative. Based on these labels, the company manages real estate assets across operating properties, land parcels, and active development or redevelopment projects. It derives revenue from rentals, leases, and direct financing leases, with segments including corporate and reportable real estate divisions. The text references life science properties such as the Alexandria Center for Life Science. However, the excerpt does not disclose the company's specific customer types or commercial tenants.
Geographically, the text references operations in North America, Canada, Texas, San Diego, Greater Boston, Miami, and Los Angeles, alongside named properties in New York City and Seattle. While the document mentions real estate assets and development projects, it does not state the total number of buildings or exact square footage. Furthermore, the provided text does not state the location of the corporate headquarters.
Summary of the business section of Alexandria Real Estate Equities's latest annual report, written by StockData.
Company profile
Company
- Legal name
- ALEXANDRIA REAL ESTATE EQUITIES, INC.
- Founded
- 1994
- Headquarters
- Pasadena, CA
- Address
- 26 North Euclid Avenue 91101
- Phone
- (626) 578-0777
- Website
- www.are.com
- Employees
- 514, Dec 31, 2025
- Industry
- Real Estate Investment Trusts
- Incorporated in
- Maryland
- Fiscal year ends
- December 31
- Auditor
- Ernst& Young LLP, Los Angeles, California
Stock & identifiers
- Ticker
- ARE
- Exchange
- NYSE
- Shares outstanding
- 174M, Jul 15, 2026
- Public float
- $12.40B, Jun 30, 2025
- Filer category
- Large accelerated filer
- SEC CIK
- 1035443
- CUSIP
- 015271109
- ISIN
- US0152711091
- LEI
- MGCJBT4MKTQBVLNUIS88
- EIN
- 95-4502084
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Joel S. Marcus | Executive Chairman, Director | 597,724 |
| Bret E. Gossett | EVP - Co-RMD | 52,370 |
| Jenna R. Foger | EVP - Co-Lead - Life Science | 67,272 |
| Blake L. Stevens | Regional Market Director | 29,064 |
| John Hart Cole | Co-President, & Co-RMD | 106,731 |
| Hallie E. Kuhn | EVP - Cap Market & Co-Lead -LS | 47,387 |
| Gregory Calvin Thomas | EVP - CTO | 31,928 |
| Michael E. Boss | Co-Regional Market Director | 51,345 |
| Jesse J. Nelson | EVP - RMD | 95,033 |
| Kristina Fukuzaki-Carlson | EVP - Business Operations | 39,152 |
| Peter M. Moglia | Chief Executive Officer | 371,954 |
| Andres Gavinet | Chief Accounting Officer | 102,516 |
| Marc E. Binda | CFO & Treasurer | 188,264 |
| Madeleine Thorp Alsbrook | EVP - Talent Management | 38,781 |
| Joshua J. Mitchell | Regional Market Director | 25,049 |
| Gary D. Dean | EVP, Real Estate Legal Affairs | 68,314 |
| Joseph Hakman | Co-Chief Operating Officer | 99,160 |
| Jackie B. Clem | General Counsel & Secretary | 73,044 |
| Orraparn C. Lee | EVP - Accounting | 68,768 |
| Hunter Kass | Co-President and RMD | 237,635 |
| Lawrence J. Diamond | Co-Chief Operating Officer | 159,890 |
| Daniel J. Ryan | Co-President and RMD | 217,609 |
| Vincent Ciruzzi | Chief Development Officer | 72,820 |
| Sheila K. McGrath | Director | 12,205 |
| James P. Cain | Director | 13,427 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Joel SMarcus | $11.57M | $4.29M | $5.01M | $34 | $165 |
| FY2025 Peter MMoglia | $8.84M | $1.50M | $5.01M | $34 | $165 |
| FY2024 Joel SMarcus | $17.73M | $14.20M | $6.76M | $63 | $128 |
| FY2024 Peter MMoglia | $10.28M | $7.51M | $6.76M | $63 | $128 |
| FY2024 Stephen ARichardson | $0 | $0 | $6.76M | $63 | $128 |
| FY2023 Joel SMarcus | $15.49M | $12.94M | $7.73M | $78 | $103 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of December 31, 2025 , we had 514 employees .”
Corporate history
Events identified from SEC filings